While donors and eventual clinical recipients vary for blood, tissues, cells and organs, a similar process-flow applies to most SoHO. the European Commission has clarified that substances of Human Origin (SoHO) are considered to be essential goods/services for which free circulation within the EU is crucial.DG Sante has published guidance on the collection and transfusion of convalescent COVID-19 plasma.ECDC has published an update of its guidance on COVID-19 and substances of human origin.the European Commission supported blood services to increase COVID-19 convalescent plasma collection.With the purpose of a better and coordinated response to the outbreak: The COVID-19 pandemic represented a challenge to public health. The overall objective is to protect citizens. vigilance activities and project support.assisting national authorities with its implementation.drafting legislation and developing guidance.To this end, it undertakes a range of activities, including 168(4)(a) of the Treaty on the functioning of the EU. The European Commission helps address these risks through its mandate to set high standards of quality and safety of SoHO, in accordance with Art. kidney transplants), and even help create life (gametes and in vitro fertilisation).ĭespite their benefits, the use of SoHO presents risks, in particular the transmission of diseases. blood transfusion in case of trauma), improve the quality of life (e.g. Treatments based on these substances of human origin (SoHO) save lives (e.g. Blood, tissues, cells and organs are used in a variety of medical therapies.
0 Comments
Leave a Reply. |